Product Information
CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2545 per EA under NDC 59651052401. Its NADAC has been published 104 times since Aug 28, 2024.
FDA first approved this application on Sep 14, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651052401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216419FDA Approved
9/14/2023
TE Code
AB
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 104 times since Aug 28, 2024, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2545 per EA |
|---|---|
| All-time high | $0.5272 (Oct 16, 2024) |
| All-time low | $0.2405 (Mar 18, 2026) |
| 52-week high | $0.3051 |
| 52-week low | $0.2405 |
| Median price | $0.2844 |
| Average price | $0.3040 |
| Largest weekly change | -26.2% (Nov 20, 2024) |
| Weeks tracked | 104 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by Aurobindo Pharma Limited, is $0.2545 per EA (NDC 59651052401), effective Aug 19, 2026.
How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 40.8%. It has been tracked across 104 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?
Since Aug 28, 2024, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2405 (Mar 18, 2026) to a high of $0.5272 (Oct 16, 2024), with a median of $0.2844 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHLORDIAZEPOXIDE-CLIDINIUM CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?
CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 59651052401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.